Observational studyBMC health services research2026
Safety and implementation of a regional hospital-at-home model: a retrospective observational study from Denmark.
Observational study in BMC health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo describe the patient population, care pathways, and short-term safety outcomes of a regional hospital-at-home model in Region Zealand, Denmark, between 2022 and 2024, and to explore variation in outcomes by diagnosis and referral source.
designRetrospective observational study using registry-based data and internal monitoring records.
settingA publicly funded, cross-sectoral hospital-at-home service coordinated centrally and delivered via municipal nurses and mobile treatment units.
participantsWe included 2,511 patients with a median age of 72 years (IQR 60-80). Patients generally presented with substantial comorbidity and represented a broad, clinically diverse population.
main outcome measuresLength of stay, unplanned hospital contacts during treatment or within 24 h after planned completion, 30-day readmissions, and 30-day survival.
resultsThe median length of stay increased from 5.1 days in 2022 to 7.3 days in 2024. Rates of unplanned hospital contacts remained stable (27.0-31.1%), whereas 30-day readmission rates declined from 11.0% to 7.0% over the study period. Thirty-day survival remained consistently high (91.6-92.4%). Infectious diseases were the most frequent diagnostic category (43-47%). Outcomes varied by diagnosis and referral source, with longer treatment durations observed among patients with orthopaedic and chronic conditions.
conclusionsHospital-level care delivered in patients' homes was implemented on a regional scale with acceptable short-term outcomes across a clinically complex and socially diverse patient population, including individuals living alone. The variation in outcomes across diagnostic groups underscores the importance of flexible, diagnosis-informed care pathways and structured cross-sectoral organisation in hospital-at-home models. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.